Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label synbiose 2 trial

HIGHLIGHTS

• who: Mieke van Schaik from the Department of Nephrology, Leiden University Medical Center, , RC Leiden, the Netherlands have published the research: Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial, in the Journal: (JOURNAL) of 20/Nov/2018
• what: The aim is to assess whether combined B cell therapy will lead to a reduction of treatment failure. The Synbiose 2 study focuses on severe SLE and LN patients which is complementary to the phase 3, randomized BLISS-BELIEVE study (NCT03312907 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.